Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

536 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effects of fusel oil on animal hangover models.
Hori H, Fujii W, Hatanaka Y, Suwa Y. Hori H, et al. Among authors: hatanaka y. Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):37S-41S. doi: 10.1097/01.ALC.0000078828.49740.48. Alcohol Clin Exp Res. 2003. PMID: 12960505
Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector.
Gao JQ, Tsuda Y, Katayama K, Nakayama T, Hatanaka Y, Tani Y, Mizuguchi H, Hayakawa T, Yoshie O, Tsutsumi Y, Mayumi T, Nakagawa S. Gao JQ, et al. Among authors: hatanaka y. Cancer Res. 2003 Aug 1;63(15):4420-5. Cancer Res. 2003. PMID: 12907614
NK cells are migrated and indispensable in the anti-tumor activity induced by CCL27 gene therapy.
Gao JQ, Tsuda Y, Han M, Xu DH, Kanagawa N, Hatanaka Y, Tani Y, Mizuguchi H, Tsutsumi Y, Mayumi T, Okada N, Nakagawa S. Gao JQ, et al. Among authors: hatanaka y. Cancer Immunol Immunother. 2009 Feb;58(2):291-9. doi: 10.1007/s00262-008-0554-x. Epub 2008 Jul 16. Cancer Immunol Immunother. 2009. PMID: 18629495
Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses.
Gao JQ, Kanagawa N, Xu DH, Han M, Sugita T, Hatanaka Y, Tani Y, Mizuguchi H, Tsutsumi Y, Mayumi T, Okada N, Nakagawa S. Gao JQ, et al. Among authors: hatanaka y. Cancer Immunol Immunother. 2008 Nov;57(11):1657-64. doi: 10.1007/s00262-008-0499-0. Epub 2008 Mar 8. Cancer Immunol Immunother. 2008. PMID: 18327579
CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma.
Kanagawa N, Niwa M, Hatanaka Y, Tani Y, Nakagawa S, Fujita T, Yamamoto A, Okada N. Kanagawa N, et al. Among authors: hatanaka y. Int J Cancer. 2007 Nov 1;121(9):2013-22. doi: 10.1002/ijc.22908. Int J Cancer. 2007. PMID: 17621629
Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer.
Yonemori K, Tsuta K, Ono M, Shimizu C, Hirakawa A, Hasegawa T, Hatanaka Y, Narita Y, Shibui S, Fujiwara Y. Yonemori K, et al. Among authors: hatanaka y. Cancer. 2010 Jan 15;116(2):302-8. doi: 10.1002/cncr.24735. Cancer. 2010. PMID: 19937674
The Anti-tumor Effect of Cabozantinib on Ovarian Clear Cell Carcinoma In Vitro and In Vivo.
Nakatani M, Watari H, Mitamura T, Wang L, Hatanaka Y, Hatanaka KC, Honda K, Nomura T, Nishihara H, Tanaka S, Sakuragi N. Nakatani M, et al. Among authors: hatanaka kc, hatanaka y. Anticancer Res. 2017 Nov;37(11):6125-6132. doi: 10.21873/anticanres.12061. Anticancer Res. 2017. PMID: 29061793
Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancer.
Oguro S, Ino Y, Shimada K, Hatanaka Y, Matsuno Y, Esaki M, Nara S, Kishi Y, Kosuge T, Hiraoka N. Oguro S, et al. Among authors: hatanaka y. Cancer Sci. 2015 Dec;106(12):1750-60. doi: 10.1111/cas.12825. Epub 2015 Oct 22. Cancer Sci. 2015. PMID: 26395180 Free PMC article.
Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
Ohata T, Yokoo H, Kamiyama T, Fukai M, Aiyama T, Hatanaka Y, Hatanaka K, Wakayama K, Orimo T, Kakisaka T, Kobayashi N, Matsuno Y, Taketomi A. Ohata T, et al. Among authors: hatanaka k, hatanaka y. Cancer Med. 2017 May;6(5):1049-1061. doi: 10.1002/cam4.1020. Epub 2017 Apr 4. Cancer Med. 2017. PMID: 28374947 Free PMC article.
Clinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Takashima Y, Sakakibara-Konishi J, Hatanaka Y, Hatanaka KC, Ohhara Y, Oizumi S, Hida Y, Kaga K, Kinoshita I, Dosaka-Akita H, Matsuno Y, Nishimura M. Takashima Y, et al. Among authors: hatanaka kc, hatanaka y. Clin Lung Cancer. 2018 Jul;19(4):352-359.e1. doi: 10.1016/j.cllc.2018.02.004. Epub 2018 Feb 19. Clin Lung Cancer. 2018. PMID: 29544718
536 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page